Inge Lues
Chief Development Officer
Business Development
Probiodrug
Germany
Biography
Inge Lues has been Chief Development Officer of Probiodrug since 2013. Dr Lues joined Probiodrug as R&D advisor in 2008. Between 2007 and 2013 Dr Lues was also advising other biotech companies, interacting with venture capital and private equity firms and acted as reviewer for public research institutions. From 2002 until early 2007, Dr Lues was Head of Global Drug Discovery and Non-Clinical Development Pharma at Merck KGaA and was a member of the Pharma Board. During Dr Lues’s leadership, she intensified oncology research, re-started diabetes research, established biomarker research in R&D and consolidated research sites including the integration of a U.S. biotech company. Between 1998 and 2002 she was heading Merck’s Business Area CNS achieving the strategic goal of out-licensing the CNS assets under development. Dr Lues received her Ph.D. in Physiology in 1978 and conducted postdoctoral training in pharmacology from 1980 – 1984.
Research Interest
Physiology
